Accumulating evidence has indicated a role for autophagy-related (Atgs) proteins in cell regulation which is independent of their autophagic activities. As the only known transmembrane protein essential for autophagy, Atg9 cycles between the trans-Golgi network (TGN) and endosomes. Here, we report a function for mammalian Atg9 (mAtg9) in the transport of lysosomal hydrolases which impacts the lysosomal degradation capacity. Depletion of mAtg9 inhibits the degradation of epidermal growth factor receptor and the maturation of cathepsin D and cathepsin L. mAtg9 interacts with adaptor protein-1 (AP1) and the cation-independent mannose-6-phosphate receptor, facilitating AP1 polymerization and the transport of cathepsin D from the TGN. These results suggest that mAtg9 may serve as a coreceptor of lysosomal hydrolases for their TGN export by cycling between the TGN and endosomes.
In eukaryotic cells, lysosomes are crucial components of the cellular degradation and recycling system, and their correct function is required to maintain proper cell homeostasis [1, 2] . Recently, it has been increasingly recognized that the degradation and recycling function of lysosomes is majorly mediated by autophagy, in addition to endocytosis and exocytosis [3, 4] . By fusion with autophagosomes, lysosomes degrade protein aggregates and damaged organelles, so that the cells can cope with poor intracellular and extracellular conditions [5, 6] . Accumulating evidence has suggested that this function of lysosomes is tightly related to multiple physiological and pathological processes such as aging, tumorigenesis, and neurodegenerations [7] [8] [9] .
The degradation activity of lysosomes relies on the large number of acid hydrolases within them and the low pH of the compartments that is maintained by the transmembrane ATP-driven proton pumps. Proteomic analyses have demonstrated that the lumen of lysosome contains approximately 60 different acid hydrolases [10] . After being synthesized in the endoplasmic reticulum and followed the secretory pathway passing through the Golgi apparatus, the hydrolases are directed directly from the trans-Golgi network (TGN) to the endosomes/lysosomes, when lysosomal Abbreviations AP1, adaptor protein-1; CDMPR, cation-dependent mannose-6-phosphate receptor; CIMPR, cation-independent mannose-6-phosphate receptor; EGFR, epidermal growth factor receptor; KD, knockdown; KO, knockout; mAtg9, mammalian Atg9; TGN, trans-Golgi network.
transmembrane proteins can also be first sorted to the cell surface and then enter the endocytic pathway [11] . Lysosomal transmembrane proteins contains tyrosineor dileucine-based consensus motifs in their cytosolic domains that serve as sorting signals to endosomes/ lysosomes, while most lysosomal acid hydrolases acquire mannose-6-phosphate (M6P) moieties that mediate their bindings with membrane receptors Man-6-P-receptor (MPRs) [12, 13] . At the TGN, the tyrosine-and dileucine-based motifs of MPRs are recognized by the clathrin adaptor complex adaptor protein-1 (AP1) which ensures them together with the associated hydrolases to be recruited into clathrincoated carriers for endosomes/lysosomes [14] . It has been shown that MPR deficiency or blockage of retrograde transport of MPR from endosomes/lysosomes to TGN impairs the maturation of lysosomal hydrolases and accelerates the excretion of immature hydrolases, leading to lysosomal storage diseases [15] [16] [17] .
Atg9 is a multispanning transmembrane protein functioning in the early stage of autophagy [18, 19] . Topological analysis indicates that both the N-terminus and C-terminus of mammalian Atg9 (mAtg9) are cytoplasma-oriented [20] . Primarily, mAtg9 is localized in the TGN and cycles between TGN, endosomes and plasma membrane, when it is also found on mitochondria [21, 22] . Upon starvation-induced autophagy, accompanied with the diminishment of its TGN-localization, mAtg9 is targeted to autophagosome precursors from endosomes, which is thought to provide membranes for the formation of autophagosomes [20, 23, 24] . Recently, it was revealed that mAtg9 colocalizes with AP1 and possesses several conserved tyrosine-and dileucine-based sorting motifs in its cytosolic domains and loops [20, 25] , which may ensure its cycling among the membranes. Despite these significant findings, the exact molecular mechanisms that regulate Atg9 trafficking under normal or starvation conditions remain elusive. Like other autophagyrelated (Atgs) proteins, Atg9 was first identified as an essential protein for autophagy by genetic approaches in yeast [26] . The fact that many Atg proteins including Atg9 function in cell regulation independent of their autophagic activities [27, 28] , the membrane trafficking and structural characters of Atg9 imply a role for this protein in intracellular membrane transport.
In this study, we have identified that mAtg9 is required for the maturation of cathepsin D and lysosomal degradation. Our data suggest that cycling between the TGN and endosomes/lysosomes enables mAtg9 to facilitate the transport of cathepsin D and perhaps other cathepsin proteins to lysosomes, by interaction with AP1 and MPR.
Materials and methods

Plasmids, antibodies, and reagents
HA-mAtg9 was a gift from Sharon A. Tooze (Cancer Research UK, UK). The point mutations for HA-mAtg9 Y8A/L11A and/or HA-mAtg9 Y785A/I788A were created by PCR-based site-directed mutagenesis using QuikChange II XL (Stratagene, La Jolla, CA, USA ) according to the manufacturer's instructions. Flag-mAtg9 was inserted into pCMV-2A vector using the EcoRI and XhoI restriction sites by quick-fusion cloning kit. Myc-AP1l1 was made by cloning the cDNA of AP1l1 into pCMV-3A vector using the EcoRI and XhoI restriction sites. mAtg9-Myc and mAtg9-Myc Y8F mutant were kindly provided by Quan Chen and Yushan Zhu from Nankai University. GFP-CIMPR and CFP-CDMPR were gifts from Satoshi Waguri (Juntendo University, Japan) and Juan S. Bonifacino (National Institutes of Health, USA) respectively. Myc-CIMPR and Myc-CDMPR were constructed by changing the GFP or CFP to Myc.
The following antibodies were used: anti-LAMP1, anti-CIMPR, anti-HA, and anti-Myc (Santa Cruz Biotech, Dallas, TX, USA); anti-EGFR (Ruiying Biological, Hangzhou, Zhejiang, China) for western blotting, anti-EGFR (Cell Signaling Technology, Danvers, MA, USA) for immunofluorescence; anti-mAtg9 (Novus Biologicals, Littleton, CO, USA) for western blotting, anti-mAtg9 (Abcam, Cambridge, UK) for immunofluorescence; anti-cathepsin D (Santa Cruz Biotech) for all the forms of cathepsin D, anticathepsin D (BD Biosciences, Franklin lake, NJ, USA) for mature cathepsin D; anti-cathepsin L (Ruiying Biological); anti-EEA1 (Cell Signaling Technology); anti-Atg5 (Novus Biologicals); anti-Atg7 (Abcam); anti-b-actin (Sigma, Darmstadt, Germany); anti-Flag (MBL, Nagoya, Aichi, Japan) and anti-Myc beads (Biotool, Houston, TX, USA ). Alexa Fluor 488-, Alexa Fluor 546-, and Alexa Fluor 635-tagged secondary antibodies for immunostaining were from Invitrogen (Carlsbad, CA, USA). The secondary antibodies for western blotting were donkey anti-mouse/rabbit IRDye680/800CW (LI-COR Biosciences, Lincoln, NE, USA); horseradish peroxidase-conjugated goat anti-mouse/ rabbit IgG (H+L) (Invitrogen). Epidermal growth factor (EGF) was from PeproTech (Rocky Hill, NJ, USA). DQ Red BSA, LysoTracker Red and BODIPY FL-pepstatin A were from Invitrogen. Chloroquine (CQ), bafilomycin A1 (Baf A1), wortmannin, and G418 disulfate salt were from Sigma-Aldrich. Puromycin was from Sangon Biotech (Shanghai, China). 
Cell cultures, transfection, and RNAi
Western blotting and immunoprecipitation
Western blotting was performed as described previously [29] . In brief, proteins obtained from lysed cells were denatured and loaded on sodium dodecyl sulfate polyacrylamide gels. Afterwards, the proteins were transferred onto poly (vinylidene difluoride) membranes, blocked in TBS (150 mM NaCl, 10 mM Tris-HCl pH 7.5) containing 3% (w/v) bovine serum albumin, and incubated with the corresponding primary and secondary antibodies. The specific bands were analyzed by an Odyssey infrared imaging system (LI-COR Biosciences) or Chemiluminescence and Fluorescence Imaging System G:Box XR5 (Syngene, Cambridge, UK). For immunoprecipitation, cells were lysed in lysis buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40) containing protease inhibitors. After centrifugation, the supernatants were either incubated with antibody overnight and then Protein A/G agarose for 3 h at 4°C, or incubated with anti-Myc/HA beads for 3 h at 4°C. Immunocomplexes were washed and analyzed by western blotting.
Immunostaining and confocal microscopy
For immunostaining, cells were fixed in 4% formaldehyde. After washing twice with PBS, cells were incubated in PBS with fetal bovine serum (10%) to block nonspecific antibody adsorption. Then, the cells were incubated with appropriate primary and secondary antibodies in blocking buffer containing 0.1% saponin. Live cell imaging was performed in LabTek chambers (Nalge Nunc International, Rochester, NY, USA) maintained at 37°C with 5% CO 2 . Images were captured on a Zeiss LSM510 or LSM800 laser scanning confocal microscope. The number of LAMP1 and BODIPY FLpepstatin A puncta were quantified using IMAGEJ software (National Institutes of Health, Bethesda, MD, USA). The fluorescence intensity of EGFR, DQ Red BSA, and LysoTracker Red were estimated using IMAGEJ software (National Institutes of Health). The data were analyzed by GRAPHPAD PRISM 5 software (San Diego, CA, USA).
Real-time PCR
Total cellular RNA was isolated using TRIzol reagent (Invitrogen) and reverse transcribed using M-MLV Reverse Transcriptase (Promega, Fitchburg, WI, USA) according to the manufacturer's protocol. Real-time PCR analysis was performed by using the SYBR GREEN PCR Master Mix (Takara, Tokyo, Japan) and the ABI7500 real-time PCR system (Applied Biosystems, Foster City, CA, USA). GAPDH was used as an internal control. Real-time PCR was performed using primers as follows: (1 
EGFR degradation and DQ Red BSA assay
After culture in serum-free DMEM for 12 h, Hela or H1299 cells were incubated on ice in serum-free DMEM containing 100 ngÁmL À1 of EGF for 15 min. The cells were washed with PBS to remove excess EGF followed by culturing in serumfree DMEM at 37°C. At indicated time points, the cells were either subjected to western blotting or fixed in 4% formaldehyde, stained with EGFR antibody and imaged by confocal microscopy. For DQ Red BSA assay, Hela cells were washed with PBS to remove serum and incubated in serum-free DMEM containing 10 lgÁmL À1 DQ Red BSA for 3 h at 37°C. The cells were washed with PBS to remove excess probe, fixed and imaged by confocal microscopy.
LysoTracker Red and BODIPY FL-pepstatin A labeling
Hela cells were cultured with 50 nM LysoTracker Red for 30 min at 37°C. HEK cells grown on LabTek chambers were incubated with 1 lM BODIPY FL-pepstatin A for 1 h at 37°C. After washing with PBS to remove the excess probes, the cells were visualized by confocal microscopy.
Analysis of cathepsin D secretion
Hela cells grown on 6 cm dish were washed with PBS to remove serum. After culturing cells in serum-free DMEM for 24 h, the cells were lysed and the culture media were harvested, centrifuged at 1000 g for 5 min to remove cells and cell debris. The culture media were concentrated using Amicon Ultra-4 Centrifugal Filter Unit with Ultracel-3 membrane (Merck, Kenilworth, NJ, USA) to a certain volume. The cell lysis and concentrated culture media were subjected to western blotting.
Gel filtration analysis
Hela cells were lysed with lysis buffer and centrifuged at 15 000 g for 15 min. The supernatant fraction was concentrated and loaded onto a Superose 6 column (GE Healthcare Life Sciences, Piscataway, NJ, USA) and eluted at a flow rate of 0.3 mlÁmin À1 with assay buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl). Aliquots from each flow through fraction were analyzed by western blotting.
Statistical analysis
All data were presented as means AE SEM. Statistical significance of the differences in the experimental data was determined using the student t test. Differences were considered significant at values of P < 0.05.
Results
Role of mAtg9 in lysosomal degradation activity
It is known that mAtg9 associates with endosomes and can be detected on lysosomes [20, 30] . To investigate a potential role of mAtg9 in lysosomal degradation, we first assessed the distribution of mAtg9 in autophagy-deficient cells. In ATG5 KO and ATG7 KO HEK293 cells, colocalizations of mAtg9 with EEA1, GFP-Rab7 and LAMP1 were detected and the colocalization coefficient resembled that in the wild-type HEK293 cells ( Figs 1A and S1 ), suggesting that localization of mAtg9 on endosomes/lysosomes is not dependent on cell autophagy. We then analyzed the breakdown of epidermal growth factor receptor (EGFR) in mAtg9-KD cells. EGFR localized primarily to the cell surface before addition of EGF. Following EGF treatment, EGFR was internalized and clustered into small puncta, and the normalized intracellular EGFR intensity reached the highest level at 15 min after EGF stimulation (Fig. 1B,C) . However, when a significant portion of the internalized EGFR was degraded in control cells, the EGFR puncta were retained in mAtg9-KD cells, indicating weakened lysosomal proteolysis (Fig. 1B,C) . This result was supported by western blotting demonstrating a lowered reduction of total cellular EGFR after EGF stimulation in mAtg9-KD cells (Fig. 1D ). In addition, both in control and mAtg9-RNAi cells, EGFR was significantly retained by lysosomal inhibitor Baf A1, confirming a specific degradation of EGFR in lysosomes (Fig. 1D) . To further confirm these observations, we used another mAtg9 shRNA and ATG9A KO cells [31] , and consistent results were obtained (Fig. S2A-F) . We also assessed lysosomal activity by observing the process of DQ Red BSA, a self-quenched lysosomal degradation indicator. Lysosomal degradation of DQ Red BSA results in release of nonquenched protein fragments that are brightly fluorescent [32] . We found that the degradation of DQ Red BSA was evidently impaired in cells with either mAtg9 KD or ATG9A KO (Figs 1E,F and S2G,H). The EGF- stimulated degradation of EGFR was not significantly affected by deletion of ATG5 or ATG7 (Fig. 1G) . Together, these results suggest that mAtg9 plays a role in maintaining lysosomal degradative capacity in an autophagy-independent manner. mAtg9 is required for the TGN export of cathepsin D and cathepsin L Normal lysosomal quantity and acidification are important for lysosomal degradation. To investigate the mechanism underlying mAtg9 KD-induced reduction in lysosomal degradation activity, we first checked the intracellular LAMP1 by western blotting and immunostaining. KD of mAtg9 changed neither the protein level of LAMP1 nor the number of LAMP1-positive puncta in cells ( Fig. 2A-C) , suggesting that mAtg9 is dispensable to the biogenesis of late endosomes/lysosomes. We then measured the acidification of lysosome using the acidotropic probe LysoTracker Red, a weak basic fluorescent dye that marks the acid organelles in the living cells [33] . No significant change in the fluorescence intensity of LysoTracker Red was detected in mAtg9-KD cells when compared to that in the control cells (Fig. 2D,E) . We then decided to investigate whether lack of mAtg9 would affect the activity of lysosomal hydrolases. We aimed cathepsin D, a major member of cathepsin family and one of the richest protease in lysosome. Cathepsin D is synthesized in the endoplasmic reticulum which is in turn cleaved and glycosylated to form 52-kDa procathepsin D containing two N-linked oligosaccharides modified with M6P residues. After transport to endosomes, it is cleaved into a 44-kDa intermediate form, which is further processed in the acidic environment of mature lysosomes to form the mature enzyme comprising noncovalently associated 31-and 14-kDa polypeptides [34] . First, we assessed the activation of cathepsin D by incubating cells with BODIPY FL-pepstatin A, which binds selectively to mature active cathepsin D [35] . BODIPY FL-pepstatin A-stained puncta representing lysosomes with mature cathepsin D was reduced dramatically in mAtg9-KD cells (Fig. 3A,B) . We then carried out western blotting experiments using an antibody which recognizes all the forms of cathepsin D. Consistent with the immunostaining results, KD of mAtg9 significantly reduced the 31-kDa mature cathepsin D in cells (Fig. 3C) . Intriguingly, different from the effect of the lysosomal inhibitor CQ, a lysosomal pH neutralizer that decreased the 31-kDa mature cathepsin D and accumulated the 44-kDa intermediate cathepsin D, mAtg9 KD-led reduction in mature cathepsin D was not accompanied by accumulation of either the 52-kDa pro-form or the 44-kDa intermediate form of cathepsin D (Fig. 3C) . Knocking down mAtg9 also dramatically decreased mature cathepsin L (Fig. 3C) , while it showed no effect to the mRNA levels of cathepsin D and cathepsin L (Fig. 3D) . Lastly, we measured cathepsin D protein in the culture medium, because impaired sorting of the precursor of cathepsins to lysosomes causes its excretion from cells [17] . We found that when mAtg9-KD decreased mature cathepsin D in the cells, it significantly increased the procathepsin D in the cell culture medium (Fig. 3E) , resulting in a similar effect to wortmannin treatment which was used as a positive control [36] . Together, these results demonstrated that mAtg9 is essential to the maturation of cathepsin D and cathepsin L. Lack of mAtg9 disrupts the transport of the cathepsins from the TGN, mimicking a phenotype of MPR depletion.
mAtg9 interacts with AP1 and CIMPR
The requirement of mAtg9 in the post-Golgi transport of cathepsins prompted us to investigate a potential role of this TGN-localized transmembrane protein in AP1-clathrin coat assembly. By searching both the cytosolic N-terminus and C-terminus, we found two putative conserved AP1-binding YXXΦ motifs sitting at each end of mAtg9 (Fig. 4A) . The C-terminal Y (785)GGI(788) had never been identified, while the Nterminal Y(8)QRL (11) has been previously reported [31, 37] . We therefore constructed mATG9 mutants in which the Y8/L11 and/or the Y785/I788 were changed to alanine via site-directed mutagenesis. We found that, in coexpressed cells, immunoprecipitation of Myc-tagged the mu subunit of AP1 (Myc-AP1l1) that recognizes the tyrosine-based sorting signals, coprecipitated HA-tagged mAtg9 (HA-mAtg9), indicating a binding of the two proteins (Fig. 4B) . Interestingly, mutation at Y785/I788 (mutant 2) only slightly attenuated the binding, while mutation at Y8/L11 (mutant 1) dramatically suppressed, and mutation at both sites abolished the binding (Fig. 4B) . These results were consistent with previous report suggesting an interaction of mAtg9 and AP1 [31] . We then wondered if mAtg9 could associate with MPR which possesses AP1-binding motifs and can form dimers. We performed coimmunoprecipitation experiments using cells expressing HA-mAtg9 and Myc-tagged cation-dependent MPR (Myc-CDMPR), and HA-mAtg9 and Myc- tagged cation-independent MPR (Myc-CIMPR). The CDMPR forms a stable homodimer and the CIMPR exists most likely as a dimer [38] . It is revealed that HA-mAtg9 was coprecipitated with immunoprecipitated Myc-CIMPR but not Myc-CDMPR (Fig. 4C) .
Immunoprecipitation of HA-mAtg9 also coprecipitated Myc-CIMPR (Fig. 4D) , confirming an association of the two proteins. Further, we found that the mAtg9-CIMPR interaction was significantly inhibited by knocking down c-adaptin, a subunit of AP1 required for targeting AP1 to golgi membrane [39] ( Fig. 4E) , and CIMPR failed to associate with mAtg9 that is unable to bind AP1 (Fig. 4F) , suggesting a mediating effect of AP1 in the mAtg9-CIMPR interaction.
mAtg9 promotes AP1-CIMPR interaction and AP1 polymerization MPR interaction with AP1 promotes the polymerization of AP1 and the recruitment of clathrin, giving rise to nascent clathrin-coated buds [40] . We then asked whether the requirement of mAtg9 in the transport of the cathepsins from the TGN might attribute to the association of mAtg9 with AP1 and CIMPR, which may promote the CIMPR-AP1 interaction and AP1 polymerization. To test a possible need of mAtg9 for the CIMPR-AP1 interaction, we checked the coimmunoprecipitation of CIMPR with AP1 using ATG9A KO Hela cells [31] . Deletion of ATG9A dramatically reduced the endogenous CIMPR coprecipitated with Myc-AP1l1 (Fig. 5A) . Expressing in the cells wildtype mAtg9, but not the double-mutated form of mAtg9, partially rescued the CIMPR-Myc-AP1l1 association (Fig. 5B) . In addition, KD of CIMPR also attenuated the association of mAtg9 with AP1 (Fig. 5C ). Furthermore, we carried out gel filtration experiments to analyze the oligomeric state of AP1.
Using an antibody against c-adaptin, we found that AP1 presented different molecular mass and formed oligomer as previously reported [40] (Fig. 5D ). Deletion of ATG9A evidently shifted AP1 from higher molecular mass fractions to lower fractions (Fig. 5D) , suggesting a function of mAtg9 in AP1 polymerization. Finally, we tested a requirement of mAtg9-AP1 interaction for cathepsin D maturation. As expected, when expression of wild-type mAtg9 partially rescued the ATG9A KO-induced reduction of mature cathepsin D, the mAtg9 mutant that unable to interact with AP1 did not (Fig. 5E ). Together, these results suggest an Recently, it has been shown that phosphorylation by Src kinase is essential to the intracellular trafficking of mAtg9 and the function of mAtg9 in starvation-triggered autophagy, by promoting the interaction of mAtg9 with AP1 and AP2 [31] . To investigate a potential role of Src-dependent phosphorylation in mAtg9-mediated cathepsin D maturation, we measured the level of mature cathepsin D in cells treated with EGF. Apparently, when mAtg9 phosphorylation at the Src-specific Y8 residue was stimulated by EGF treatment [31] , the intracellular mature cathepsin D increased (Fig. 5F ). In addition, when mature cathepsin D level reduced dramatically by ATG9A KO, it was partially rescued by reintroduction in the cells of WT mAtg9 but not a Y8-unphosphorylatable mAtg9 mutant (Fig. 5G) . Finally, we checked the maturation of cathepsin D in nutrientstarved cells. We found that deprivation of either glucose or amino acid from cells evidently raised intracellular mature cathepsin D, when the interaction between mAtg9 and AP1 in the cells was markedly enhanced (Fig. 5H) . These results therefore suggest that Src-dependent phosphorylation is required for the function of mAtg9 in mediating cathepsin D maturation, possibly through enhancing mAtg9-AP1 interaction on the TGN. and Myc-AP1l1 for 24 h, and then starved in glucose-free or amino acid-free medium for 2 h. Cells were collected for immunoprecipitation with anti-Myc. Then, the immunoprecipitates and cell lysates were analyzed by western blotting using HA and mature cathepsin D antibody, respectively.
Discussion
In this study, we have revealed that mAtg9, a key transmembrane Atg functioning in the early stage of autophagy, is required for the post-Golgi transport and maturation of lysosomal hydrolases. This role of mAtg9 is conferred by its interaction with AP1 which facilitates AP1-CIMPR binding and the consequent AP1 polymerization. While the molecular mechanism for the role of Atg9 in autophagy and the significance for its cycling between the intracellular membranes remain largely unknown, our data suggest that the distinctive intracellular localization and trafficking of mAtg9 are not only for the targeting of itself to the phagophore for autophagosome formation, but also for protein transport in cells. Considering that Atg9 is well-conserved in eukaryotic cells, this multitransmembrane protein which possesses both AP1-and AP2-binding motifs, may be a constitutive component of the intracellular membrane trafficking system and might be involved in the transport of other cargo proteins besides cathepsins. This possibility is supported by the fact that mAtg9 can be phosphorylated by Src kinase which facilitates the interaction between Atg9 and AP1/AP2. Because it is known that multiple members of Src kinase family cycle between the plasma membrane, the Golgi complex, and the endosomes [41] [42] [43] , and are involved in the transport of various cargoes between these membrane compartments [44, 45] . When it is still unclear why abolishing the Src-dependent phosphorylation that prevents mAtg9 from interacting with AP1 and AP2, can increase mAtg9 on the plasma membrane [31] , our data suggest that the phosphorylation contributes to the post-Golgi transport of cathepsin D. The phosphorylation of mAtg9 may occur either on the plasma membrane or on the TGN by activated Src from the plasma membrane.
Our data suggest that mAtg9 interaction with AP1 facilitates the binding of AP1 with cathepsin receptor CIMPR possibly through forming complex with CIMPR on the membrane. KD of AP1 attenuates the coprecipitation of mAtg9 with CIMPR indicating that formation of the complex is at least partially mediated by AP1. Nevertheless, mAtg9 specifically associates with CIMPR but not CDMPR, implying a possible direct interaction between the two transmembrane proteins. KD of CIMPR also attenuates the interaction between mAtg9 and AP1 suggesting that CIMPR and mAtg9 can synthetically function in the membrane recruitment of AP1. The oligomerization of transmembrane cargoes or cargo receptors has long been recognized to be essential for packaging cargo proteins into transport vesicles. It is generally believed that the assembly of transmembrane cargoes would not only drive membrane remodeling at the vesicle formation sites, but more importantly strengthen the affinity of the transmembrane cargoes for coat proteins [46] . It is known that MPR can undergo dimerization. But possibly, MPR dimers are not strong enough for driving the polymerization of AP1 on the TGN membrane. Through interaction with AP1 and form complex with CIMPR, mAtg9 may serve as a helper of CIMPR for AP1 polymerization and subsequent the assembly of clathrin coat. It would be certainly meaningful to investigate in future whether mAtg9 itself could function as a cargo receptor through interacting with cargoes with its lumen-oriented loops.
It is of note that the acidification of endosomes/ lysosomes is unaffected by mAtg9 deletion, suggesting that mAtg9 is not involved in the transport of the proton pump V-ATPase required for lysosomes. This is consistent with the findings showing that lysosomal targeting of such a multiprotein complex exhibits an additional level of complexity compared with the acid hydrolases, and possibly through a direct MPR-independent TGN-to-lysosome transport pathway [47, 48] .
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